COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
发明人:
Franck Mouthon,Mathieu Charveriat
申请号：
US14907221
公开号：
US20160158213A1
申请日:
2014.07.24
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to the use of flecainide as an anti-connexin agent. This anti-connexin agent is advantageously used to potentiate the therapeutic effect of various psychotropic drugs. More specifically, the invention provides a combination product containing flecainide and modafinil.
